Progenics Pharmaceuticals (PGNX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | PGNX | TSHA | GBIO | ||
| Company | Progenics Pharmaceuticals | Taysha Gene Therapies Inc | Generation Bio Co. | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 4.60 | 2.35 | 3.06 | ||
| High | 4.79 | 2.45 | 3.11 | ||
| Low | 3.94 | 2.30 | 2.85 | ||
| Last | 4.10 | 2.39 | 2.90 | ||
| Change | -0.43 | +0.09 | -0.11 | ||
| % Change | -9.39% | +3.91% | -3.65% | ||
| Volume | 34,928,300 | 890,100 | 92,000 | ||
| 20-Day Average Volume | 2,569,575 | 1,821,360 | 219,930 | ||
| Previous Close | 4.53 | 2.30 | 3.01 | ||
| Industry | Medical - Generic Drugs | Medical - Generic Drugs | Medical - Generic Drugs | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 4.30 | 2.65 | 3.53 | ||
| 20-Day Raw Stochastic | 31.13% | 19.52% | 10.26% | ||
| 20-Day Relative Strength | 49.46% | 46.92% | 45.96% | ||
| Weighted Alpha | -27.10 | +0.03 | +8.44 | ||
| Today's Opinion | 8% Sell | 56% Buy | 24% Buy | ||
| Previous Opinion | 16% Buy | 56% Buy | 40% Buy | ||
| Last Month's Opinion | 72% Sell | 88% Buy | 40% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +1.49% since 06/12/20 | +5.29% since 04/19/24 | +3.57% since 04/19/24 | ||
| Low | 3.86 on 06/15/20 | 2.16 on 04/25/24 | 2.75 on 04/22/24 | ||
| High | 4.79 on 06/19/20 | 2.61 on 04/23/24 | 3.40 on 04/23/24 | ||
| 1-Month | |||||
| %Chg | +12.95% since 05/19/20 | -21.90% since 03/26/24 | -8.52% since 03/26/24 | ||
| Low | 3.72 on 05/20/20 | 2.14 on 04/19/24 | 2.70 on 04/19/24 | ||
| High | 4.83 on 06/08/20 | 3.40 on 04/10/24 | 4.65 on 04/01/24 | ||
| 3-Month | |||||
| %Chg | +94.31% since 03/19/20 | +61.49% since 01/26/24 | +62.92% since 01/26/24 | ||
| Low | 2.05 on 03/20/20 | 1.41 on 02/14/24 | 1.75 on 01/29/24 | ||
| High | 4.83 on 06/08/20 | 3.55 on 03/01/24 | 4.65 on 04/01/24 | ||
| 6-Month | |||||
| %Chg | -21.76% since 12/19/19 | -1.65% since 10/26/23 | +202.68% since 10/26/23 | ||
| Low | 1.89 on 03/19/20 | 1.27 on 11/14/23 | 0.89 on 10/27/23 | ||
| High | 6.37 on 12/23/19 | 3.55 on 03/01/24 | 4.65 on 04/01/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 355,048 | 446,973 | 192,818 | ||
| Shares Outstanding, K | 86,597 | 187,018 | 66,489 | ||
| Annual Sales | 34,990,000 | 15,450,000 | 5,900,000 | ||
| Annual Net Income | -68,550,000 | -111,570,000 | -126,610,000 | ||
| Last Quarter Sales | 6,250,000 | 3,600,000 | 2,880,000 | ||
| Last Quarter Net Income | -16,800,000 | 47,740,000 | -35,190,000 | ||
| 60-Month Beta | 1.89 | 0.29 | 2.79 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 0.35 on 03/19/24 | -0.53 on 03/06/24 | ||
| Latest Earnings Date | 08/14/20 | 05/09/24 | 05/08/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||